Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
People
CFOs On the Move: Week Ending March 24
Ally Financial, NFL, Papa Johns, Overair, LastPass, Curbio, Hinge Health, Momnt, Sealed Air, Infobip
By
Lauren Muskett
| March 24, 2023
Read More
Resources
Reports
Reports
2023
2022
Featured
People
CFOs On the Move: Week Ending March 24
Ally Financial, NFL, Papa Johns, Overair, LastPass, Curbio, Hinge Health, Momnt, Sealed Air, Infobip
By
Lauren Muskett
| March 24, 2023
Read More
Sign Up
Menu
Reports
2023
2022
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
Sign Up
Sponsored by
drug distributors
Investor Relations
Big Health Care Companies Are Undervalued
McKesson and Walgreens are strong, healthy companies, despite recent downturns in their stock prices, a CEO in the investment field says.
By
David McCann
| July 1, 2019
Read More
Investor Relations
‘Threats’ to McKesson Don’t Hold Up
The drug distributor will remain a value stock despite some perceived threats, including the White House's aim to restructure pharmaceutical pricing.
By
Vitaliy Katsenelson
| January 25, 2019
Read More
